Joachim-Friedrich Kapp

SVP, Clinical Development, Autoimmunity at Aditx Therapeutics

Brings over 3 decades of experience with regulatory agencies such as the FDA and its European counterparts. Board-certified in Pharmacology & Toxicology, and Clinical Pharmacology. Former President Global Business Unit (GBU) Specialized Therapeutics at Schering AG.

Links